The state of the fight:Pfizer/BioNTech’s Comirnaty appeared to offer only 12% effectiveness against Omicron in children ages 5-11.
South Africa’s Biovac partnered with nine development institutions to boost local vaccine manufacturing capacity.
Eli Lilly’s arthritis drug Olumiant reduced the risk of death by 13% in hospitalized Covid-19 patients. AUTHORIZED VACCINES
Pfizer/BioNTech’s Comirnaty is far less protective against infection in children…